Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
January 1, 2017
Burst inflation test for measuring biomechanical properties of rat abdominal walls
V D Mahalingam, B C Syverud, A M Myers, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
June 29, 2017
Tissue-engineered tendon constructs for rotator cuff repair in sheep
Stoyna S Novakova, Vasudevan D Mahalingam, Shelby E Florida, et al.
Oncogene
|
October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma
K R Kelly, C M Espitia, D Mahalingam, et al.
British Journal of Cancer
|
April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
D Mahalingam, G Wilding, S Denmeade, et al.
The Journal of Endocrinology
|
August 20, 2011
Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone
Chandrika D Mahalingam, Tanuka Datta, Rashmi V Patil, et al.
Tissue Engineering. Part C, Methods
|
November 15, 2014
Fresh versus frozen engineered bone-ligament-bone grafts for sheep anterior cruciate ligament repair
Vasudevan D Mahalingam, Nilofar Behbahani-Nejad, Elizabeth A Ronan, et al.
Tissue Engineering. Part A
|
November 15, 2014
Allogeneic versus autologous derived cell sources for use in engineered bone-ligament-bone grafts in sheep anterior cruciate ligament repair
Vasudevan D Mahalingam, Nilofar Behbahani-Nejad, Storm V Horine, et al.
British Journal of Cancer
|
October 22, 2011
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
D Mahalingam, C M Espitia, E C Medina, et al.
ESMO Open
|
May 22, 2025
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer
D Mahalingam, A Saeed, S F Powell, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
January 1, 2017
Burst inflation test for measuring biomechanical properties of rat abdominal walls
V D Mahalingam, B C Syverud, A M Myers, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
June 29, 2017
Tissue-engineered tendon constructs for rotator cuff repair in sheep
Stoyna S Novakova, Vasudevan D Mahalingam, Shelby E Florida, et al.
Oncogene
|
October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma
K R Kelly, C M Espitia, D Mahalingam, et al.
British Journal of Cancer
|
April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
D Mahalingam, G Wilding, S Denmeade, et al.
The Journal of Endocrinology
|
August 20, 2011
Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone
Chandrika D Mahalingam, Tanuka Datta, Rashmi V Patil, et al.
Tissue Engineering. Part C, Methods
|
November 15, 2014
Fresh versus frozen engineered bone-ligament-bone grafts for sheep anterior cruciate ligament repair
Vasudevan D Mahalingam, Nilofar Behbahani-Nejad, Elizabeth A Ronan, et al.
Tissue Engineering. Part A
|
November 15, 2014
Allogeneic versus autologous derived cell sources for use in engineered bone-ligament-bone grafts in sheep anterior cruciate ligament repair
Vasudevan D Mahalingam, Nilofar Behbahani-Nejad, Storm V Horine, et al.
British Journal of Cancer
|
October 22, 2011
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
D Mahalingam, C M Espitia, E C Medina, et al.
ESMO Open
|
May 22, 2025
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer
D Mahalingam, A Saeed, S F Powell, et al.
Page
of 2